Concord Healthcare Group Co (HKSE:02453) Marketable Securities: HK$0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02453 Concord Healthcare Group Co Ltd HKSE:02453
41 GF Score
Price HK$0.77
GF Value HK$8.63
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Concord Healthcare Group Co Marketable Securities?

Concord Healthcare Group Co HKSE:02453 -5.52% 41 Marketable Securities is HK$0.0 Mil as of Jun. 2026. GuruFocus rates HKSE:02453 with a GF Score™ of 41/100 and a GF Value™ of HK$8.63 (Possible Value Trap). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Concord Healthcare Group Co's Marketable Securities for the quarter that ended in Jun. 2026 was HK$0.0 Mil.

Concord Healthcare Group Co's annual Marketable Securities increased from Dec. 2023 (HK$0.0 Mil) to Dec. 2024 (HK$141.5 Mil) but then declined from Dec. 2024 (HK$141.5 Mil) to Dec. 2025 (HK$0.0 Mil).

Concord Healthcare Group Co  (HKSE:02453) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Concord Healthcare Group Co Marketable Securities Related Terms

Concord Healthcare Group Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Concord Healthcare Group Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Concord Healthcare Group Co Marketable Securities Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 0.00 141.55 0.00

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 223.01 141.55 0.00 0.00 0.00
HKSE:02453
41GF Score
Concord Healthcare Group Co Ltd HKSE:02453
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Concord Healthcare Group Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of HK$0.0 Mil mean?
Concord Healthcare Group Co (HKSE:02453) has a Marketable Securities of HK$0.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Concord Healthcare Group Co and its competitors.
Is Concord Healthcare Group Co's Marketable Securities too high?
Concord Healthcare Group Co's current Marketable Securities is HK$0.0 Mil. Overall, Concord Healthcare Group Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Concord Healthcare Group Co's Marketable Securities compare to HCA and THC?
Concord Healthcare Group Co's Marketable Securities of HK$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Concord Healthcare Group Co and its competitors. Concord Healthcare Group Co's current Marketable Securities is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Healthcare Group Co stock overvalued right now?
Based on GuruFocus' analysis, Concord Healthcare Group Co (HKSE:02453) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.63, compared to a current price of HK$0.77 — trading 91.1% below its estimated fair value. The current Marketable Securities is HK$0.0 Mil. Concord Healthcare Group Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Concord Healthcare Group Co (HKSE:02453), the current Marketable Securities is HK$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Concord Healthcare Group Co (HKSE:02453) Overvalued in 2026?

Based on GuruFocus' analysis, Concord Healthcare Group Co stock appears to be undervalued. The current stock price of HK$0.77 is trading 91.1% below its estimated GF Value™ of HK$8.63. GuruFocus considers Concord Healthcare Group Co to be Possible Value Trap.

Key valuation signals for HKSE:02453:

  • Marketable Securities: HK$0.0 Mil
  • GF Value™: HK$8.63 vs. price of HK$0.77 (91.1% below fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the HKSE:02453 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Concord Healthcare Group Co Business Description

Address No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The Group owns and operates four offline self-operated medical institutions and one medical institution under construction, dedicated to providing comprehensive and specialized medical services to cancer patients. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
41GF Score

Get the complete analysis for HKSE:02453

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.77
Price
HK$8.63
GF Value